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ADHESION MOLECULES IN THE KIDNEY
Adhesion molecules in the glomerular mesangium
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Adhesion molecuJes in the glomerutar mesangium. Experimental evi-
dence indicates that extensive "cross-talk" exists between glomerular cells,
extracellular matrix molecules and soluble mediator substances affecting
the proliferative and secretory phenotype of glomerular mesangial cells.
Both matrix and cytokines regulate mesangial cell behavior in vitro and in
vivo after binding to specific cell surface receptors. It appears as if the
concerted action of insoluble and soluble ligands on mesangial cells
involves a reciprocal regulation of matrix molecules and cytokines as well
as expression and affinity of their respective receptors. Elucidation of the
potential biologic and clinical relevance of cell-matrix interactions in the
glomerular mesangium represents a challenging goal in current kidney
research. This brief review summarizes recent investigations concerning
regulation of expression and function of adhesion molecules and matrix
receptors in the mesangium. In addition to results from cell culture
studies, descriptive findings on expression and regulation of adhesion
molecules and their potential role for altered mesangial cell behavior in
glomerular disease is considered.
The mesangium represents a specialized pericapillary tissue in
the glomerulus. It consists of non-polarized, contractile, myofi-
broblast-like mesangial cells (MCs) and extracellular matrix
(ECM). In the normal adult mammalian glomerulus, the mesan-
gial space is mostly restricted to an axial or centrolobular position
(Fig. 1).
However, in some parts of the glomerulus, MCs surround the
circumference of capillaries [fl. This is in keeping with the
concept that contractile, pericapillary MCs contribute to the
regulation of the glomerular microcirculation and ultrafiltration.
Structure and function of the mesangium have been reviewed
[2—6]. This article attempts to summarize the available informa-
tion on adhesion of MCs to ECM components, emphasizing
findings on function and modulation of ECM adhesion receptors.
The role of cell-cell adhesion in MC interactions with other cells
(endothelial or inflammatory cells) has been the subject of recent
reviews [7, 8] and will not be discussed here. Table I lists the main
functional properties of MCs and the mesangium. All of them
require to a larger or smaller extent interactions of MCs with
ECM and with other cells. This is particularly obvious with respect
to mesangial support and maintenance of the capillary tuft
architecture.
Lobular disintegration of the mesangium with mesangial cell
detachment and death (so-called mesangiolysis) is found in cer-
tain types of human glomerular disease and in experimental
glomerulopathies [5, 9]. Mesangiolysis leads to aneurysms of the
glomerular capillaries and loss of their lobular arrangement. As
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holds for all anchorage-dependent cells [10—131, adhesion of MCs
to the surrounding ECM is a prerequisite for many functions and
properties, including contraction and migration as well as survival,
proliferation and expression of a differentiated phenotype [2, 3,
14—16].
MC adhesion molecules
Cell adhesion and other interactions of cells with components
of the ECM are mediated by specific cell surface receptors, of
which integrins are the most abundant. Integrins constitute a
family of heterodimeric transmembrane glycoproteins consisting
of non-covalently associated a and /3 subunits that both bind to
ECM ligands and are linked to cytoskeletal elements [10, 131. The
/3, subunit family of integrins has been shown to be most relevant
for binding of cells to various components of the underlying or
surrounding ECM. Studies of glomeruli in kidney tissue sections
and of MCs in culture have confirmed that glomerular MCs as
well as endothelial and visceral epithelial cells express multiple
integrins (Table 2) [2, 3, 7, 8, 15—21].
This list of adhesion receptors is likely to grow once new
integrins become identified. At present, the dominant a chains
expressed by human and rat MCs are a1, a3, a5, a8, and a. These
MC surface receptors can bind to and interact with a variety of
ligands, some of which are listed in Table 3.
The number and diversity of ligands which can interact with one
or more integrins is large and growing [10, 12, 13]. Besides many
ECM components and cell surface proteins, pathogenic ligands
have been identified, including bacterial and viral proteins [12]. It
is presently unknown whether such exogenous ligands interact
with MC integrins and are of relevance in vivo. Of conceptual
interest are the so-called disintegrins, which are short ligands for
integrins and appear to act as competitive inhibitors of ligand-
integrin binding [12, 22]. First found in snake venoms, a number
of endogenous soluble and cell surface disintegrins have been
identified that may play a role in the physiologic or pathogenic
regulation of cell-ECM interactions. However, their potential
relevance in the mesangium is presently unclear.
I, integrins connect the ECM with the cytoskeleton and
provide a mechanical or physical linkage. As receptors, they also
transmit information from the ECM context into the cell and are
involved in ECM-controlled signaling events that modulate mul-
tiple cellular functions. Conceptually, one can distinguish adhe-
sion-related functions of integrins (including cell anchorage,
development and organization of tissues, contraction and migra-
tion) from functions that induce cellular changes due to non-
adhesion-dependent signaling initiated by ligand-integrin binding
(Table 4). The latter includes induction of expression and/or
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Fig. 1. Schematic structure of mammalian
glomerular capilla,y (CAP) lobule. Abbreviations
are: EC, endothelial cell; MC, mesangial cell;
VEPC, visceral epithelial cell; MP, macrophage;
TH, thrombocytes; ECM, extracellular matrix
consisting of mesangial matrix and glomerular
basement membrane (GBM); adhesion
molecules on MC surfaces connect with EC and
ECM components and with MP and TH during
inflammatory processes.
Table 1. Functional properties of mesangial cells
1. Structural support of glomerular capillary tuft
2. Contractility allowing modulation of glomerular microcirculation and
ultrafiltration
3. Migration during embryonic development and reconstitution of
injured glomeruli
4. Endocytosis/clearing function
5. Endothelium-like properties and functions
• anti-thrombogenic properties
• non-leukocyte adherent surface
• source of vasoactive molecules
6. Response to local injury
• MC proliferation
• formation of soluble regulator molecules with autocrine and/or
paracrine effects
• formation, breakdown, remodeling of mesangial matrix and
GBM
7. Interaction of activated MCs with immune complexes and immune
cells
Table 2. Expression of adhesion molecules in glomerular ceIls
Mesangial Endothelial Epithelial
Integrins
/3i a1
133
Cell surface
proteoglycans
Selectins
Ig superfamily VCAM-1
path.: ICAM-!
_______ ________ ______
path.: ELAM-1
path., expression found in diseased tissue or stimulated cells in culture
and affinity of other cell surface receptors, such as 13 integrins [28,
29].
activation of other cell surface receptors, gene expression, cell
differentiation, survival as well as assembly and disassembly of
ECM [23—271. Thus, ligation and activation of the various J3
integrin adhesion receptors on MCs are likely to play a critical
role in the regulation of the MC phenotype in culture and in vivo.
Besides /3 and /33 integrins, cell surface proteoglycans also
function in the mediation of cell-matrix and cell-cell interactions
[24, 28—30]. They include the syndecan family [28, 29] and the cell
surface antigen CD 44 [31]. Expression of both types of molecules
has been demonstrated on MCs (Table 3). The available infor-
mation on fibroblasts and MCs indicates that they bind to various
ligands and can serve as co-receptors modulating the expression
Formation of focal adhesions by MCs
As anchorage-dependent cells, MCs form focal adhesions or
focal contacts when plated on ECM substrata. Focal contacts
allow cells to anchor to their environment (Fig. 2). They are
transmembranous assemblies of multiple molecules, including
extracellularly the ECM ligand and clusters of the transmembra-
nous integrin receptors. Intracellularly, a submembranous plaque
is formed containing a complex of cytoskeletal proteins, including
paxillin, talin, a-actinin, tensin and vinculin. These and other
components provide linkage to actin filament bundles, important
for cell shape change, contraction and migration. Elements in-
volved in signal transduction via /3 integrins include a-actinin,
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a2
a3
a2
a5 a5
a2
Syndecan 4
CD44
path.: ICAM-1
Syndecan 1
CD44
path.: E-selcctin
path.: ICAM-1
path.: VCAM-1
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Table 3. ECM receptor expression in the mesangiuma
Receptor Ligands
Hu
Tissue
man
Cells6
Rat
Tissue Cells
j31-integrins
a Coil, Col IV, LN + + + + + + +
02 CoiI,CoIIV,LN + (+) (+) (+)
03 CoIl, FN, LN + + + +
04 VCAM-l, LN, FN — - - -
05 FN,RGD + ++ + ++
06 LN (E8 fragment) —
07 LN — — —
a FN, others + + + + +
p3-integrin
a VN, FN, RGD, others + + + + +
CeH surface
proteoglycans
Syndecan 4 FN, VN, LN ? + (+) +
CD44 Hyai, Col, FN, LN (+) + (+) +
Abbreviations are: Col, collagen; LN, laminin; FN, fibronectin; VN,
vitronectin; Hyal, hyaluronan.
a Detected by immunochemistry on normal kidney sections or in
cultured mesangial cells
h Results dependent on the ECM substratum used for MC culture; see
text for references
vinculin, talin, tensin, PKCa, Grb2, syndecan-4 and 125F [23,
241. MCs organize only those f3 integrins into focal adhesions,
which are used to interact with the underlying matrix molecules.
On collagen I, MCs organize a1131, a2f31 and 03133, on EHS
laminin aj3 and a3131, on fibronectin a3f31 and a5131 into focal
contacts [32]. No evidence is currently available showing that the
expression of the f3 integrins is regulated by the underlying
substrate at the level of gene transcription [32].
Although interaction of integrins with ECM ligands has to take
place in order to induce their organization into focal adhesion
sites, this process does not necessarily achieve and mediate cell
adhesion. For example, the aV133 integrin is moved into MC focal
adhesions on contact with fibronectin, although this is not re-
quired to mediate MC adhesion to fibronectin.
In the signal transduction cascade following MC adhesion and
focal contact formation, the phosphotyrosine kinase p125FAK
seems to be of particular importance [26, 33]. pl25' is phos-
phorylated after binding of p, 132 or 133 integrins to their
respective substrate. In MCs, it was shown that p125F is
phosphorylated after integrin clustering induced by exposure to
various stimuli, such as ET-1 or thrombin [33, 31. The effect of
ET-l is likely to be mediated via PKC activation, since treatment
with staurosporine or calphostin C and prolonged pre-treatment
with TPA antagonizes the phosphoiylation of p125FAK in re-
sponse to ET-1. In contrast, p125F1K phosphorylation can be
stimulated in MCs by short-term treatment with TPA activating
PKC.
Regulation of MC adhesion receptors
At present, there is very little information with respect to the
regulation of MC adhesion receptors. It has been demonstrated
that MC-ECM interactions via specific adhesion receptors occur
in concert with effects of soluble regulators, such as cytokines,
which also specifically bind to MC surface receptors and affect cell
behavior. Indeed, expression and activation of J3 integrins appear
to be modulated by cytokines. For example, TGF-f3 has been
Table 4. Functions of adhesion molecules/ECM receptors
Cell adhesion-related functions ("physical linkage")
— cell anchorage
— tissue organization and maintenance
embiyogenesis and tissue remodeling/repair
— transmission of contractile forces to cytoskeleton/reorganization of
actin microfilaments/contraction
— cell shape change
-dynamic alterations of adhesion (attachment/detachment):
• mitosis
• migration
Signal transduction ("chemical linkage")
— (co-) receptor function with stimulatory or inhibitory signals for:
• expression, conformation and affinity of cell surface receptors,
including adhesion molecules ("inside-out signals")
• cell polarity
• cell differentiation
• cell proliferation
• cell survival/apoptosis
• ECM metabolism and assembly/disassembly
shown to elevate the a3, a3 and /3 chains at the mRNA and
protein level in fibroblasts and glomerular cells [14, 181.
TGF-f3 is one of the most extensively studied cytokines in the
regulation of ECM metabolism and has been shown to be an
important mediator of ECM build-up in several chronic diseases,
including glomerulosclerosis [351. TGF-13 stimulates the produc-
tion of various matrix components, inhibits matrix degradation
and modulates ECM receptors to increase cell adhesion. In
cultured MCs, TGF-/3 induces the production of the matrix
components laminin and collagen I, as well as a13 and a5133
integrin mRNA and protein. It stimulates MC adhesion to
collagen I and fibronectin. In isolated normal glomeruli, TGF-f3
was shown to stimulate synthesis of a1/31 and a5131 integrins [18].
In an experimental model of mesangioproliferative disease, ele-
vated glomerular expression of the a1, a5, and f3 integrin chains
correlated with the up-regulation of TGF-133 in the mesangium.
Furthermore, accumulation of laminin, collagen, and fibronectin,
that is, ligands for a1/31 and a5133 integrins, was observed [18].
These data suggest that TGF-j3 induces increased glomerular f3
integrin expression and augments MC-matrix interactions by
up-regulating the expression of matrix receptors and of their
ligands. The mechanism how TGF-p regulates the expression of
individual integrin subunits is presently unclear. Results from
other cell lines indicate that the expression of integrin subunits is
differentially regulated by TGF-p. For instance, in rat alveolar
epithelial cells TGF-133 increased expression of 06131, while ex-
pression of the a3f33 receptor was decreased [361. Thus, TGF-13
may influence cell function and differentiaton by causing switches
in the pattern of ECM receptors. Other cytokines such as bFGF,
PDGF, or EGF have also been shown to modulate integrin
expression in different cell types [37, 38]. Similarly, IL-1p, IFNy
and TNFa can elevate the expression of various receptors of
cell-matrix and cell-cell adhesion [7, 8].
Since the involvement of these and other cytokines in glomer-
ular inflammatory processes has been demonstrated in experi-
mental disease models and in human pathology [3—5], it is
conceivable that the effects of cytokines on glomerular cell
behavior may be partly due to altered expression and activation of
adhesion receptors. This could affect the MC phenotype, for
,)1+- Sr.
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Fig. 2. Immunocytochemical staining of focal adhesion components. Human MCs were seeded onto fibronectin. After four hour adhesion time, MCs
were stained with monoclonal antibodies to the 05 integrin chain, focal adhesion kinase pl25' and talin. The microphotographs show that these
components are localized in MC focal adhesions.
example with regards to cell proliferation, survival or apoptosis, as
well as ECM assembly.
Besides soluble cytokines and growth factors, non-soluble ECM
constituents can also affect localization and function of f3 inte-
grins [32]. This has been shown in various cell types grown on
different ECM substrates, such as fibronectin, laminin and colla-
gens. Based on these findings, it can be hypothesized that in
glomerular disease when different ECM constituents are newly
expressed, glomerular cells may also be induced to change their
expression of adhesion receptors, allowing new kinds of MC-ECM
interaction. Promoting further ECM production and assembly,
this may be relevant for progressive mesangial ECM build-up and
glomerular scarring. On the other hand, reduction or lack of
physiologic ECM constituents may also lead to abnormal MC
behavior, such as due to loss of tonic deactivating effects on the
MC phenotype. In this context, recent findings are of interest
which demonstrated that various glycosaminoglycans and proteo-
glycans can interfere with binding and adhesion of cells to ECM
components. For example, the small dermatan sulfate proteogly-
can, decorin, is able to inhibit fibroblast adhesion to several ECM
proteins, including thrombospondin and flbronectin [39].
Since the heparan sulfate proteoglycan, perlecan, is a key
constituent of the glomerular basement membrane and is also
present in mesangial ECM, we explored whether it may act as a
regulator for MC adhesion to ECM proteins in culture [21]. MCs
readily attach to and spread on substrata containing fibronectin,
laminin or collagens whereas they do not adhere to perlecan.
Moreover, MC adhesion to fibronectin but not to laminin or
collagen I was inhibited in a specific, dose-dependent fashion
when perlecan was added to the substratum (Fig. 3).
Further experiments showed that perlecan exerted its anti-
adhesive effects on MCs predominantly via a core protein-
dependent mechanism that appeared to reduce the avidity of the
fibronectin receptor, af3 integrin. While induction of 05131
integrin organization into focal contacts was not impaired by
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Fig. 3. Perlecan specifically inhibits MC adhesion to flhronectin (FN; A)
and to the 120 kDa cell-binding fragment of FN (Y). Rat MCs were seeded
Onto culture dishes which had been coated with FN, laminin (LN; 0), or
120 kDa cell-binding fragment of FN. Uncoated culture plastic served as
control (Ky). Dishes were additionally coated with increasing concentra-
tions of perlecan. Perlecan itself ( ) did not mediate MC adhesion (1 hr).
Perlecan specifically inhibited the adhesion of MCs to FN and its 120 kDa
fragment, but had no effect on the MC adhesion to LN.
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perlecan, the resulting receptor avidity level seemed too low for
mediating MC binding to and spreading on fibronectin [21]. These
results are consistent with the concept that mesangial perlecan
modulates the activating effects of fibronectin on the MC pheno-
type in vivo, thus contributing to the maintenance of the glomer-
ular architecture. It remains to be elucidated whether perlecan
down-regulates the affinity of the fibronectin-binding 13 integrin
in a direct or indirect fashion. Also, it is unclear whether loss of
this anti-adhesive mechanism in vivo may facilitate fibronectin-
induced MC proliferation and ECM increase in chronic glomeru-
lopathies, where reduced perlecan abundance has been reported
[40].
Regulation of MC proliferation by ECM
Growth of MCs is controlled by many soluble regulator mole-
cules, including cytokines, growth factors, autacoids and hor-
mones. Experimental evidence in different cell systems has re-
vealed that the ECM components can also modulate the
proliferative phenotype of MCs. In vitro, freshly seeded MCs do
not only plate with higher efficiency on collagen types I, III and IV
compared to plastic but may also show greater replication activity
[41]. Thrombospondin (TSP) increases MC proliferation, an effect
that might be mediated by up-regulation of EGF and PDGF
secretion [42]. TSP has anti-adhesive effects on MCs in culture.
Whether the decrease of MC-ECM attachment is related to the
growth-promoting action of TSP is presently uncertain. Heparan
sulfate was shown to dose-dependently inhibit MC proliferation in
culture [43]. The inhibitory effect of perlecan on MC-fibronectin
adhesion and its potential to modulate the MC phenotype has
been discussed above. Also, proteoglycans are able to bind and
sequester various cytokines. For example, bFGF as well as TGF-f3
strongly bind to heparan sulfate proteoglycans. Since bFGF has
been reported to influence experimental kidney diseases, local
storage could represent another regulatory function of glomerular
proteoglycans. Morita and co-workers demonstrated that heparan
sulfate proteoglycans show enrichment of bFGF-binding domains
in fibrotic areas of glomeruli and peritubular interstitium [44].
Taken together, these reports demonstrate the ability of certain
ECM molecules to bind and sequester growth factors, possibly
providing a local "reservoir" of regulatory proteins and presenting
them to adjacent cells in a biologically more active form. At
present, however, the in vivo relevance of this notion is uncertain.
Considering the growth-regulatory potential of ECM for MCs,
recent studies performed in fibroblasts are of interest which have
explored the molecular basis of adhesion-dependent cell growth
on the level of cell cycle regulation. Cell cycle progression is
controlled by cyclin-dependent kinases (cdks), whose enzymatic
activity activity is modulated by association with different cyclins,
functioning as regulatory subunits. In mammalian cells, several
classes of cyclins have been identified, which can associate with
different cdk catalytic subunits [4, 45]. These include D-type
cyclins (Dl, D2, D3) and cyclin E which are involved in controlling
GI phase progression and entry into S phase. One major signaling
event allowing progression through Gi phase is phosphorylation
and inactivation of the retinoblastoma tumor suppressor protein
[4, 45]. Zhu and coworkers demonstrated that adhesion of fibro-
blasts induces cyclin Dl mRNA and is required for activation of
the cyclin E-cdk2 complex and subsequent phosphorylation of the
retinoblastoma protein, an effect which is possibly mediated by
down-regulation of the nuclear cdk inhibitor proteins, p21 and
p27 [45]. Similarly, Fang et al showed that the cyclin E-cdk2
complex was activated in attached human fibroblasts but not in
fibroblasts maintained in suspension. This lack of cyclin E-cdk2
activity in suspended cells appeared to result from an increased
expression of cdk 2 inhibitors [46]. Taken together, these obser-
vations suggest a mechanism for anchorage-dependent cell growth
that requires both, growth factors as well as an appropriate ECM
context for the transit of cells through the Gi phase and entry into
the S phase.
In addition to the requirement of cell anchorage for prolifera-
tion, the expression pattern of adhesion molecules may also
directly influence cell cycle progression. For example, expression
of integrin p1C, an alternatively spliced variant of integrin /3k,
inhibited growth of fibroblasts by blocking cell cycle progression in
the late GI phase, near the G1-S boundary [47]. Recent studies
have provided new insight into MC growth control by soluble
regulators. For example, TGF-131-induced cell cycle arrest in MCs
involves inhibition of cdk2 activation and retinoblastoma protein
phosphorylation [48]. Analogous studies are in progress to help
clarify the nuclear signaling events which mediate ECM effects on
MC survival and proliferation.
ECM and regulation of apoptosis of MCs
The abnormal mesangial ECM deposition and build-up in
glomerular disease has been described in great detail [2, 3, 5, 16,
18, 35]. In contrast, few data exist concerning ECM involvement
in repair mechanisms regulating recovery from injury and restor-
ing structural and functional integrity of the glomerulus. A novel
aspect concerning resolution of glomerular pathology points
towards a possible role of MC-matrix interactions in the induction
of cell removal by programmed cell death or apoptosis in the
recovery phase of glomerulonephritic disease. Baker et al dem-
onstrated MC apoptosis to be a major cell clearance mechanism
counterbalancing cell division in self-limited anti-Thy 1.1 glomer-
ulonephritis, thereby mediating decline of glomerular hypercellu-
larity in experimental MC proliferation [49]. It has been shown in
several cell types, including endothelial cells and epithelial cells,
that loss of adhesion can induce apoptosis, an effect which is often
abolished in tumor cells [11]. Recent data support the notion that
apoptosis may be dependent on and regulated by the expression
and signaling of distinct sets of cell adhesion molecules. For
example, antibodies to 13 integrins induced apoptosis in epithelial
cells [50]. Moreover, Zhang et al found in CHO cells that
expression of nf31 integrin but not of the closely related aP1
integrin, which binds fibronectin on the same RGD motif, appears
to suppress apoptosis through the bcl-2 pathway [511. Thus, it is
conceivable that integrin-mediated signaling in MCs regulates cell
survival or induction of apoptosis in vivo and may thereby
contribute to glomerular repair processes.
Modulation of MC adhesion by nitric oxide
For survival and maintenance of structure and function, MCs
depend on anchorage to ECM within the three-dimensional
architecture of the glomerular capillary tuft. Detachment of
various anchorage-dependent cell types has been shown to lead to
apoptosis [11]. Recent investigations by Mühl, Brtine and
Pfeilschifter [52] have demonstrated that donors of nitric oxide
(NO) can induce apoptosis of rat MCs in culture. Moreover, it is
known that the cytokine-inducible NO synthase can be expressed
in MCs to produce large amounts of NO [531. Interestingly, NO
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Fig. 4. Effects of the NO donors SNAP and SNP on adhesion of rat MCs to
collagen I. MCs were seeded onto collagen I coated wells and incubated
with the indicated concentrations of SNAP (•) and SNP (El). Adherent
cells were counted after one hour. After washing at one hour, the number
of adherent cells was compared to the number of cells seeded and was
expressed as percent adhesion (Yao et al, unpublished observations).
synthase inhibition with L-NMMA has been reported by Narita et
a! [9] to prevent early mesangiolysis in glomeruli of rats with
anti-Thy 1.1 nephritis. Based on these different observations, we
hypothesized that NO interferes with adhesion-related functions
of ECM receptors in MCs. In the initial studies, we noted that
various NO donors, including SNAP and SNP, inhibit rat MC
adhesion and spreading on various substrata [541. This anti-
adhesive action of NO was most pronounced when MCs were
seeded onto collagen I (Fig. 4), and was less obvious on fibronec-
tin, laminin and collagen IV. The inhibitory effects were time and
dose dependent. Importantly, cytotoxicity of the NO donors on
MCs was negligible at the employed dosage and incubation time.
Additional experiments have shown that NO donors also cause
rounding and detachment of adherent MCs. The precise mecha-
nism involved in the observed anti-adhesive effect of NO on
cultured MCs and its relevance for the regulation of the MC
phenotype, such as for cell survival, proliferation, apoptosis and
other adhesion-related functions, remain to be clarified. However,
these in vitro findings support the hypothesis that local release of
high NO concentrations might contribute to MC detachment and
mesangiolysis in vitro [9].
In view of the remarkable abundance of adhesion molecules in
MCs and because of MC embedding in ECM of varying compo-
sition in the normal or abnormal mesangium, the potential exists
that the proliferative as well as apoptotic phenotype of MCs is
greatly influenced by expression and activity of integrin receptors.
It remains to be seen whether this concept is relevant for the
regulation of MC behavior in glomerular development, mainte-
nance and inflammation, and whether such processes of integrin-
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